Growing evidence supports a role of chaperones in mediating such effects, as shown in mouse and fly models of Huntington’s disease (56–58) or in SOD1 cellular models of amyotrophic lateral sclerosis (ALS) (59). This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.